Improved metabolic parameters of people with diabetes attending an Aboriginal health service in regional Victoria
© 2022 The Authors. Internal Medicine Journal published by John Wiley & Sons Australia, Ltd on behalf of Royal Australasian College of Physicians..
BACKGROUND: Aboriginal and Torres Strait Islander people have higher rates of diabetes and its complications than non-Aboriginal people. Rumbalara Aboriginal Co-operative is the major primary healthcare provider for Aboriginal people in the Greater Shepparton region.
AIMS: To evaluate the baseline metabolic parameters and presence of diabetes complications in people with type 2 diabetes attending Rumbalara Aboriginal Co-operative in 2017 and compare it with other Aboriginal and Torres Strait Islander studies and Australian specialist diabetes services.
METHODS: Clinical and biochemical characteristics, including diabetes type, age, weight, body mass index (BMI), blood pressure, micro- and macrovascular complications, glycosylated haemoglobin (HbA1c), haemoglobin, renal function, lipid profile, urine albumin:creatinine ratio, diabetes medications, renin angiotensin system inhibition therapies, HMG-CoA reductase inhibitors and antiplatelet agents, were determined.
RESULTS: One hundred and twenty-six individuals had diabetes, 121 had type 2 diabetes. One hundred and thirteen identified as Aboriginal and/or Torres Strait Islander. Median age was 57.5 (48-68) years, median HbA1c was 7.8% (6.8-9.6) and median BMI was 33.4 kg/m2 (29-42.3). Compared with other Australian Aboriginal and Torres Strait Islander populations, this population was older and had more obesity, but with better glycaemia management. Compared with specialist diabetes services, this population was of similar age, with greater BMI but comparable HbA1c.
CONCLUSIONS: Aboriginal people living with type 2 diabetes attending this regional Aboriginal health service have comparable glycaemic management to specialist diabetes services in Australia, managed largely by primary care physicians with limited access to specialist care for the past 5 years.
| Medienart: |
E-Artikel |
|---|
| Erscheinungsjahr: |
2023 |
|---|---|
| Erschienen: |
2023 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:53 |
|---|---|
| Enthalten in: |
Internal medicine journal - 53(2023), 5 vom: 08. Mai, Seite 787-797 |
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Eer, Audrey S [VerfasserIn] |
|---|
| Links: |
|---|
| Themen: |
Aboriginal |
|---|
| Anmerkungen: |
Date Completed 25.05.2023 Date Revised 17.07.2023 published: Print-Electronic Citation Status MEDLINE |
|---|
| doi: |
10.1111/imj.15856 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
NLM342389378 |
|---|
| LEADER | 01000naa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM342389378 | ||
| 003 | DE-627 | ||
| 005 | 20231226014012.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 231226s2023 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1111/imj.15856 |2 doi | |
| 028 | 5 | 2 | |a pubmed24n1141.xml |
| 035 | |a (DE-627)NLM342389378 | ||
| 035 | |a (NLM)35717668 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 1 | |a Eer, Audrey S |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Improved metabolic parameters of people with diabetes attending an Aboriginal health service in regional Victoria |
| 264 | 1 | |c 2023 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ƒaComputermedien |b c |2 rdamedia | ||
| 338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Date Completed 25.05.2023 | ||
| 500 | |a Date Revised 17.07.2023 | ||
| 500 | |a published: Print-Electronic | ||
| 500 | |a Citation Status MEDLINE | ||
| 520 | |a © 2022 The Authors. Internal Medicine Journal published by John Wiley & Sons Australia, Ltd on behalf of Royal Australasian College of Physicians. | ||
| 520 | |a BACKGROUND: Aboriginal and Torres Strait Islander people have higher rates of diabetes and its complications than non-Aboriginal people. Rumbalara Aboriginal Co-operative is the major primary healthcare provider for Aboriginal people in the Greater Shepparton region | ||
| 520 | |a AIMS: To evaluate the baseline metabolic parameters and presence of diabetes complications in people with type 2 diabetes attending Rumbalara Aboriginal Co-operative in 2017 and compare it with other Aboriginal and Torres Strait Islander studies and Australian specialist diabetes services | ||
| 520 | |a METHODS: Clinical and biochemical characteristics, including diabetes type, age, weight, body mass index (BMI), blood pressure, micro- and macrovascular complications, glycosylated haemoglobin (HbA1c), haemoglobin, renal function, lipid profile, urine albumin:creatinine ratio, diabetes medications, renin angiotensin system inhibition therapies, HMG-CoA reductase inhibitors and antiplatelet agents, were determined | ||
| 520 | |a RESULTS: One hundred and twenty-six individuals had diabetes, 121 had type 2 diabetes. One hundred and thirteen identified as Aboriginal and/or Torres Strait Islander. Median age was 57.5 (48-68) years, median HbA1c was 7.8% (6.8-9.6) and median BMI was 33.4 kg/m2 (29-42.3). Compared with other Australian Aboriginal and Torres Strait Islander populations, this population was older and had more obesity, but with better glycaemia management. Compared with specialist diabetes services, this population was of similar age, with greater BMI but comparable HbA1c | ||
| 520 | |a CONCLUSIONS: Aboriginal people living with type 2 diabetes attending this regional Aboriginal health service have comparable glycaemic management to specialist diabetes services in Australia, managed largely by primary care physicians with limited access to specialist care for the past 5 years | ||
| 650 | 4 | |a Journal Article | |
| 650 | 4 | |a Aboriginal | |
| 650 | 4 | |a cardiovascular | |
| 650 | 4 | |a diabetes complications | |
| 650 | 4 | |a diabetes mellitus | |
| 650 | 7 | |a Glycated Hemoglobin |2 NLM | |
| 700 | 1 | |a Hearn, Tracey |e verfasserin |4 aut | |
| 700 | 1 | |a Atkinson-Briggs, Sharon |e verfasserin |4 aut | |
| 700 | 1 | |a Drake, Shannon |e verfasserin |4 aut | |
| 700 | 1 | |a Singh, Satpal |e verfasserin |4 aut | |
| 700 | 1 | |a Neoh, Sandra |e verfasserin |4 aut | |
| 700 | 1 | |a Pyrlis, Felicity |e verfasserin |4 aut | |
| 700 | 1 | |a Hachem, Mariam |e verfasserin |4 aut | |
| 700 | 1 | |a Zajac, Jeffrey D |e verfasserin |4 aut | |
| 700 | 1 | |a Burchill, Luke J |e verfasserin |4 aut | |
| 700 | 1 | |a O'Brien, Richard C |e verfasserin |4 aut | |
| 700 | 1 | |a Ekinci, Elif I |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Internal medicine journal |d 2001 |g 53(2023), 5 vom: 08. Mai, Seite 787-797 |w (DE-627)NLM113582811 |x 1445-5994 |7 nnns |
| 773 | 1 | 8 | |g volume:53 |g year:2023 |g number:5 |g day:08 |g month:05 |g pages:787-797 |
| 856 | 4 | 0 | |u http://dx.doi.org/10.1111/imj.15856 |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |d 53 |j 2023 |e 5 |b 08 |c 05 |h 787-797 | ||